Research Finder JSON Research - Stand Up To Cancer

Give Now

Research Finder JSON Research

{“posts”:[{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Uncovering Mutant TP53 Dependencies in Spontaneously-Arising Triple-Negative Breast Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Bile Duct, Breast”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Resistance to PARP Inhibitor Plus Anti-PD1 Therapy Driven by ER Stress and Bioactive Lipids in Ovarian Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Pediatric SU2C Catalyst® Research Grant with support from BMS: Immunomodulation to Treat Poor-Prognosis Pediatric Brain Tumors”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Brain/Nervous System”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”Pediatric SU2C Catalyst® Research Grant with support from BMS: Tumor Infiltrating Lymphocyte Adoptive T-Cell Therapy for Non-Small Cell Lung Cancer (NSCLC)”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2019″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Precision Combinatorial Immunotherapeutic Targeting of Thymic Stromal Lymphopoietin Receptor (TSLPR) Signaling in Pediatric and Young Adult CRLF2-Rearranged ALL”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Leukemia (all types), Pediatric – Blood Related”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Antigenicity of Mutant Kras and Impact on Cancer Evolution”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Bile Duct, Non – site Specific”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Non-invasive Monitoring of Tumor Phenotype by Interrogation of Plasma Cell Free RNA”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Bile Duct, Lung”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Laura Ziskin Prize: McArthur & Formenti”,”type”:”research_project”,”url”:””,”grant_term”:”2019″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Immunotherapy, Radiation Therapy”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”Pediatric SU2C Catalyst® Research Grant with support from BMS: Clinical Translation of Novel Immune-Based Combination Therapies for Pediatric Hypermutant Cancers”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Leukemia (all types), Liver, Lung, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian, Pancreatic, Pediatric – Blood Related, Pediatric – Solid Tumor, Prostate, Sarcoma, Stomach, Testicular, Other”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Canada Metastatic Breast Cancer Dream Team: Targeting mRNA Translation To Effectively Treat Metastatic Breast Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.ca/the-science/metastatic_breast_cancer_dream_team/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”Pancreatic Cancer Collective Research Team: Computational Approaches To Identifying High-Risk Pancreatic Cancer Populations – Identification of Genomic and Immune Factors in High-Risk Populations for Pancreatic Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/pcc-ai-genomic-immune-factors/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Computational Approaches To Identifying High-Risk Pancreatic Cancer Populations – Identifying Individuals at High Risk of Pancreatic Cancer through Machine Learning Analysis of Clinical Records and Images”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/pcc-ai-identifying-individuals/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”SU2C Meg Vosburg T-cell Lymphoma Dream Team: Tailoring CAR-based Immunotherapy Strategies to T-cell Lymphoma”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/t-cell-lymphoma-dream-team/”,”grant_term”:”2019″,”cancer_type_terms_string”:”Lymphoma”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”Pancreatic Cancer Collective Research Team: Combined Targeting of MEK1/MEK2 and Autophagy for Pancreatic Cancer Therapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/combined-targeting-and-autophagy-for-pancreatic-cancer/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Bile Duct, Pancreatic”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Immunotherapy Targeting Mutant KRAS”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/immunotherapy-targeting-mutant-kras/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Molecularly Targeted Radionuclide Therapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/molecularly-targeted-radionuclide-therapy/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Radiation Therapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Adoptive Transfer of TGF-β Resistant TIL to Defeat Immunosuppressive PDAC”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/adoptive-transfer/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Exploiting DNA Repair Gene Mutations in Pancreatic Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/exploiting-dna-repair/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Bile Duct, Pancreatic”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Targeting SHP2 in Pancreatic Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/targeting-shp2/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Bile Duct, Pancreatic”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”Pancreatic Cancer Collective Research Team: Targeting Stem Cell Signals in Pancreatic Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/research-teams/targeting-stem-cell-signals/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Bile Duct, Pancreatic”,”treatment_type_terms_string”:””,”grant_type_terms_string”:”Research Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Interrogating Impact of Epigenetic Modifiers on Durable Reprogramming of Exhausted CD8 T Cells in Patients with NSCLC Treated with PD-1 Blockade”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Defining Effective T-Cell Response in Viral and Non-Viral Gynecologic Cancers”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Cervical, Ovarian”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C–Lustgarten Foundation For Pancreatic Research Interception Research Team: Developing Novel Approaches to Treat and Evaluate Early Pancreatic Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/research-teams/pancreatic-cancer-interception-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Radiation Therapy, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Research Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Characterizing Immuno-variability in Children Following Standard of Care Treatment to Enable Precision Assignment to Immunotherapy Trials”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Cupid-Seq-High Throughput Transcriptomic Spatial Mapping of Immune-Tumor Interactions in the Micro-Environment”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Studies of Colorectal Cancer Patient-Derived Organoids to Validate Candidate Biomarkers of Resistance to Natural Killer Cells”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Colorectal”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Laura Ziskin Prize: Jonkers & Piwinick-Worms”,”type”:”research_project”,”url”:””,”grant_term”:”2018″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”SU2C–LUNGevity Foundation–American Lung Association Lung Cancer Interception Dream Team: Intercept Lung Cancer Through Immune, Imaging, and Molecular Evaluation (InTIME)”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/lung-cancer-interception-intime-dream-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Lustgarten Foundation Pancreatic Cancer Interception Dream Team: Intercepting Pancreatic Cancer in High-Risk Cohorts”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/pancreatic-interception-high-risk-cohorts-dream-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Single-Cell Multi-omics Convergence Research Team: Single-Cell Functional Multi-omics to Characterize and Monitor CAR T Therapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/single-cell-multi-omics-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Leukemia (all types), Lymphoma”,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Endometrial Cancers Convergence Research Team: Responders and Nonresponders to Endometrial Cancers With Mismatch Repair Deficiencies”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/endometrial-cancers-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Endometiral/Uterin”,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Cancer Susceptibility Convergence Research Team: Correlating Immunological Health to Cancer Susceptibility”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/cancer-susceptibility-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:””,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Multiple Myeloma Dream Team: Screening and Interception of Precursor Myeloma”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/precursor-myeloma-dream-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Multiple Myeloma”,”treatment_type_terms_string”:”Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Lustgarten Foundation Pancreatic Cancer Convergence Research Team: Computational Deconstruction of Neoantigen-TCR Degeneracy for Cancer Immunotherapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/neoantigen-tcr-degeneracy-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Natural Killer Cells Convergence Research Team: Integrating Experimental and Computational Pipelines to Develop Biomarkers of Tumor Cell Resistance to NK Cells”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/natural-killer-cells-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:””,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Machine Learning for Immunotherapy Convergence Research Team: Machine Learning for Cancer Immunotherapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/machine-learning-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C Gynecologic Cancers Convergence Research Team: Connecting Immune Health and Tumor Biology in Gynecologic Cancers”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/gynecologic-cancers-convergence-research-team/”,”grant_term”:”2018″,”cancer_type_terms_string”:”Endometiral/Uterin”,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Convergence Team”},{“title”:”St. Baldrick’s Foundation–SU2C Pediatric Cancer Dream Team: Immunogenomics to Create New Therapies for High-Risk Childhood Cancers”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/intractable-pediatric-cancers-dream-team/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–LUNGevity–American Lung Association Lung Cancer Interception Research Team: Blood-Based Early Interception of Lung Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/research-teams/lung-cancer-interception-research-team/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Merck: Combined Epigenetic Therapy and Pembrolizumab for Advanced Non-Small Cell Lung Cancer (NSCLC)”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Immune-oncology Checkpoint Inhibitors Have Brought About a Paradigm Shift in the Treatment of Multiple Tumor Types”,”type”:”research_project”,”url”:””,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma, Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C Catalyst® Research Grant with Support from Merck: Pembrolizumab and Radiation Therapy to improve Outcome in High-Risk Sarcoma”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Sarcoma”,”treatment_type_terms_string”:”Immunotherapy, Radiation Therapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Aptamer-based Detection and Binding of Peptide-MHC Complexes”,”type”:”research_project”,”url”:””,”grant_term”:”2017″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Dissecting the Epigenetic Mechanisms of Repeat RNA Regulation in Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2017″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Epigenetic Therapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Probing the Metabolic Interactions Between Tumor and Stroma in Pancreatic Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2017″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C–Lustgarten Foundation CAR T Research Team: Chimeric Antigen Receptor T Cell (CAR T) Therapy for Pancreatic Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/research-teams/car-t-therapy-for-pancreatic-cancer-research-team/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Research Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Merck: DNA Repair Therapies for Ovarian Cancer”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Breast, Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Merck: Targeting VDR to make Pancreatic Cancer Competent for Immunotherapy”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from BMS: Tumor Infiltrating Lymphocyte Adoptive T Cell Therapy for Non-Small Cell Lung Cancer (NSCLC)”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from BMS: Immunotherapy to Prevent Progression in Multiple Myeloma”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Multiple Myeloma”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from BMS: Reversing Primary Anti-PD-1 Resistance with Ipilimumab and Nivolumab”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from BMS: Combined Approaches by Immune Checkpoint Inhibition for Hypermutant Cancers”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Leukemia (all types), Liver, Lung, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian, Pancreatic, Pediatric – Blood Related, Pediatric – Solid Tumor, Prostate, Sarcoma, Stomach, Testicular, Other”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Radiation Therapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Genentech: Neoadjuvant Therapy for Patients with High-Risk Stage III Melanoma”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Genentech: Overcoming Urothelial Cancer Atezolizumab Resistance by Epigenetic Therapy”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Bladder, Kidney, Other”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Catalyst® Research Grant with Support from Genentech: Immunotherapy Combination Strategies in ER-positive Metastatic Breast Cancer”,”type”:”research_project”,”url”:”https://progress.standuptocancer.org/catalyst”,”grant_term”:”2017″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Catalyst Team”},{“title”:”SU2C Innovative Research Grant: Targeting the Pro-metastatic Niche in the Liver for Cancer Immunotherapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Liver, Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Reworking Negative Receptor Signals for Improved Anti-glioma T-Cell Therapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Brain/Nervous System”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Harnessing Dipeptidyl Peptidase Inhibition for Cancer Immunotherapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Rescuing T Cell Function for Immunotherapy of Pediatric Malignancies”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: T cell Immunotherapy for Core Binding Factor Acute Myeloid Leukemia”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Imaging CAR T Cells with a Dual Function PET Reporter Gene”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Identifying and Targeting Mechanisms of Resistance to Immunotherapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Potentiating Novel Engineered Cellular Therapies for Solid Tumors”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Brain/Nervous System”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Delineating the Role of the Microbiome in Modulating Tumor and Host Immunity”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Reprogramming Tumor Immunogenicity With STING-Activating Nanoparticles”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2017-irg-recipients/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Brain/Nervous System, Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Colorectal Cancer Dream Team: Targeting Genomic, Metabolic, and Immunological Vulnerabilities of Colorectal Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/colorectal-cancer-vulnerabilities-dream-team/”,”grant_term”:”2017″,”cancer_type_terms_string”:”Colorectal, Non – site Specific, Pediatric – Blood Related”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Prevention, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Functional Verification of DNA Repair Mutations in Prostate and Ovary Tumors”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Ovarian, Prostate”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Laura Ziskin Prize: Phosphatidylinositol 3-kinase d Inhibition to Treat Patients With Relapsed or Refractory Follicular Lymphoma”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Lymphoma”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Fingerprinting the Systemic Microbiome in Plasma to Predict Immunotherapy Outcomes in Melanoma”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Defining the Role of Epigenetics in Chimeric Antigen Receptor T Cell Therapy for CLL”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Towards Predictive Models of Immunotherapy Response”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Lung, Melanoma, Non – site Specific, Pancreatic”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Checkpoint Inhibition in Children with Ultra-Mutated Cancer Due to Biallelic Mismatch Repair Deficiency (bMMRD)”,”type”:”research_project”,”url”:””,”grant_term”:”2016″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C Innovative Research Grant: Uncovering How Rad51 Paralog Mutations Contribute to Cancer Predisposition”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Phospholipid Messengers as Drivers of Dendritic Cell Dysfunction in Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Algorithmically driven Quantitative Combination Cancer Therapy Engineering”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Cellular Plasticity in Individual Basal-Type Breast Cancer Cells”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Metabolic Reprogramming Using Oncolytic Viruses to Improve Immunotherapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: “Weak Links” in Cancer Proteostasis Networks as New Therapeutic Targets”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Multiple Myeloma, Prostate”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Deubiquitinating Enzymes as Novel Anticancer Targets”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Imaging Cell-Level Heterogeneity in Solid Tumors for Personalized Treatment”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Defining the Metabolic Dependencies of Tumors”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Defining the Mechanistic Connections Between Injury, Regeneration, and Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2016-irg-recipients/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Liver”,”treatment_type_terms_string”:”Epigenetic Therapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C–Cancer Research UK–Lustgarten Foundation Pancreatic Cancer Dream Team: Reprogramming of Transcriptional Circuitry to Control Pancreatic Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/reprogramming-of-pancreatic-cancer-dream-team/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Canada–Canadian Cancer Society Breast Cancer Dream Team: Translational Development of Novel Drugs Targeting Tumor Vulnerabilities”,”type”:”research_project”,”url”:”https://standuptocancer.ca/su2c-canada-canadian-cancer-society-breast-cancer-dream-team/”,”grant_term”:”2016″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–National Science Foundation Drug Combinations Convergence Research Team: Rational Design of Anticancer Drug Combinations with Dynamic Multi-Dimensional Input”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/rational-design-of-anticancer-drug-combinations-convergence-research-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Liver, Lung, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian, Pancreatic, Prostate, Sarcoma, Stomach, Testicular, Other”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C–National Science Foundation–Lustgarten Foundation Pancreatic Cancer Convergence Research Team: Liberating T-Cell Mediated Immunity to Pancreatic Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/mediated-immunity-in-pancreatic-cancer-convergence-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Other”,”grant_type_terms_string”:”Convergence Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Targeting Epigenetic Plasticity and Drug Resistance in Pediatric Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Chemotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Identification and Analysis of Prostate Reactive TCRs for T-cell Mediated Adoptive Cellular Immunotherapy of Metastatic Prostate Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Prostate”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”SU2C–Breast Cancer Research Foundation Breast Cancer Convergence Research Team: Ecology of the Tumor Microenvironment in Breast Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/breast-cancer-tumor-microenvironment/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Prevention, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Convergence Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Development of a High-Throughput Method to Sceen Drugs with Organoids”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Screening/ Early Detection”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Cross-talk Between Histone H3K4 Mono-methylation and Cancer Metabolism to Explore New Therapeutic Strategies”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Leukemia (all types), Non – site Specific”,”treatment_type_terms_string”:”Epigenetic Therapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Laura Ziskin Prize: Identification of Drivers of APOBEC3B Function”,”type”:”research_project”,”url”:””,”grant_term”:”2015″,”cancer_type_terms_string”:”Breast, Non – site Specific”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”SU2C–National Science Foundation Lung Cancer Convergence Research Team: Genetic, Epigenetic, and Immunological Underpinnings of Cancer Evolution Through Treatment”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/convergence-teams/cancer-evolution-convergence-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Leukemia (all types), Lung”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy, Other”,”grant_type_terms_string”:”Convergence Team”},{“title”:”SU2C–American Cancer Society Lung Cancer Dream Team: Targeting KRAS Mutant Lung Cancers”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/targeting-kras-mutant-lung-cancers-dream-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Ovarian Cancer Research Alliance–National Ovarian Cancer Coalition Ovarian Cancer Dream Team: DNA Repair Therapies for Ovarian Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/dna-repair-thearpies-for-ovarian-cancer-dream-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Prevention, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Dutch Cancer Society Colorectal Cancer Early Detection Dream Team: Molecular Early Detection of Colorectal Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/colorectal-cancer-early-detection-dream-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Colorectal”,”treatment_type_terms_string”:”Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Canada Cancer Stem Cell Dream Team: Targeting Brain Tumour Stem Cell Epigenetic and Molecular Networks”,”type”:”research_project”,”url”:”https://standuptocancer.ca/su2c-canada-cancer-stem-cell-dream-team/”,”grant_term”:”2015″,”cancer_type_terms_string”:”Brain/Nervous System, Head and Neck, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: cBioPortal for Stand Up To Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: The Intersection of Epigenetic and Immune Checkpoint Therapy”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Lung, Non – site Specific”,”treatment_type_terms_string”:”Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Clinical Development of CFI-400945, a PLK4 Inhibitor, in Breast Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Analysis of High-Dimension Single-Cell Data from Cancer Immunotherapy Clinical Trials”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Lung, Melanoma, Non – site Specific”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”The Jim Toth Sr. Breakthrough Lung Cancer Research Award: Clinical trials of epigenetic therapy sensitized patients with advanced non-small cell lung cancer to chemotherapy and immunotherapy”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”The Jim Toth Sr. Breakthrough Lung Cancer Research Award”},{“title”:”Van Andel Institute–SU2C Cancer Epigenetics Dream Team: The Epigenetics Dream Team II”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/epigenetics-dream-team-ii/”,”grant_term”:”2014″,”cancer_type_terms_string”:”Bile Duct, Colorectal, Gall Bladder, Leukemia (all types), Liver, Lung, Multiple Myeloma, Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”Phillip A. Sharp Innovation in Collaboration Award: Determinants of Sensitivity and Resistance to MEK-Based Targeted Therapies in NRAS Mutant Melanomas”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Phillip A. Sharp Innovation in Collaboration Award”},{“title”:”Laura Ziskin Prize: Rational Combination Therapy for ER Positive Breast Cancer”,”type”:”research_project”,”url”:””,”grant_term”:”2014″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Laura Ziskin Prize”},{“title”:”SU2C–Farrah Fawcett Foundation Human Papillomavirus (HPV) Research Team: Therapeutic CD8 Vaccines Against Conserved E7 HPV Epitopes Identified by MS”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/research-teams/hpv-research-team/”,”grant_term”:”2014″,”cancer_type_terms_string”:”Cervical, Colorectal, Head and Neck”,”treatment_type_terms_string”:”Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Research Team”},{“title”:”SU2C–Lustgarten Foundation Pancreatic Cancer Dream Team: Transforming Pancreatic Cancer to Treatable Disease”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/transforming-pancreatic-cancer-dream-team/”,”grant_term”:”2014″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Dutch Cancer Society Tumor Organoids Dream Team: A New Preclinical Model for Drug Sensitivity Analysis”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/tumor-organoids-preclinical-models-dream-team/”,”grant_term”:”2014″,”cancer_type_terms_string”:”Colorectal, Pancreatic, Prostate”,”treatment_type_terms_string”:”Chemotherapy, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C−Dutch Cancer Society Translational Research Team: Prospective Use of DNA-Guided Personalized Cancer Treatment”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/research-teams/dna-guided-care-research-team/”,”grant_term”:”2013″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Liver, Lung, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian, Pancreatic, Prostate, Sarcoma, Stomach, Testicular, Other”,”treatment_type_terms_string”:”Chemotherapy, Immunotherapy, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Research Team”},{“title”:”SU2C–St. Baldrick’s Foundation Pediatric Cancer Dream Team: Immunogenomics to Create New Therapies for High-Risk Childhood Cancers”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/high-risk-pediatric-cancers-dream-team/”,”grant_term”:”2013″,”cancer_type_terms_string”:”Pediatric – Blood Related, Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Cancer Research Institute Cancer Immunology Dream Team: Immunologic Checkpoint Blockade and Adoptive Cell Transfer in Cancer Therapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/immunologic-checkpoint-blockade-dream-team/”,”grant_term”:”2013″,”cancer_type_terms_string”:”Kidney, Lung, Melanoma, Prostate”,”treatment_type_terms_string”:”Immunotherapy”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Prostate Cancer Foundation Prostate Dream Team: Targeting Adaptive Pathways in Metastatic Castration-Resistant Prostate Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/metastatic-treatment-resistant-prostate-cancer-dream-team/”,”grant_term”:”2013″,”cancer_type_terms_string”:”Prostate”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”Laura Ziskin Prize: Epigenetic Therapy Sensitizing Breast Cancer Blockades of DNA Repair”,”type”:”research_project”,”url”:””,”grant_term”:”2012″,”cancer_type_terms_string”:”Breast, Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy”,”grant_type_terms_string”:””},{“title”:”SU2C−Prostate Cancer Foundation Prostate Dream Team: Precision Therapy of Advanced Prostate Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/prostate-cancer-precision-therapy-dream-team/”,”grant_term”:”2012″,”cancer_type_terms_string”:”Prostate”,”treatment_type_terms_string”:”Chemotherapy, Prevention, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C–Melanoma Research Alliance Melanoma Dream Team: Personalized Medicine for Patients with BRAF Wild-Type (BRAFwt) Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/melanoma-braf-wildtype-dream-team/”,”grant_term”:”2012″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Chemotherapy, Prevention, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Innovative Research Grant: Developing New Therapeutic Strategies for Soft-Tissue Sarcoma”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Pediatric – Solid Tumor, Sarcoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Identification and Targeting of Novel Rearrangements in High-Risk ALL”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Inhibiting Innate Resistance to Chemotherapy in Lung Cancer Stem Cells”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Lung”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting MLL in Acute Myeloid Leukemia”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Chemotherapy”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Genetic and Metabolic Networks in T-ALL”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Protein Quality Control for Cancer Therapy”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting PP2A and the Glutamine-Sensing Pathway as Cancer Treatment”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Chimeric RNAs Generated by Trans-Splicing and Their Implications in Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Pediatric – Solid Tumor, Prostate, Sarcoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Exome Sequencing of Melanomas With Acquired Resistance to BRAF Inhibitors”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: A Systems Approach to Understanding Tumor Specific Drug Response”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Melanoma”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Sleeping Cancer Cell”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Framing Therapeutic Opportunities in Tumor-Activated Gametogenic Programs”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Coupled Genetic and Functional Dissection of Chronic Lymphocytic Leukemia”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2011-irg-recipients/”,”grant_term”:”2011″,”cancer_type_terms_string”:”Leukemia (all types)”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Circulating Tumor Cell Dream Team: Bioengineering and Clinical Applications of Circulating Tumor Cell Chip”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/circulating-tumor-cells-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Bile Duct, Bladder, Brain/Nervous System, Breast, Cervical, Colorectal, Endometiral/Uterin, Esophogeal, Gall Bladder, Head and Neck, Kidney, Liver, Lung, Melanoma, Mesothelioma, Ovarian, Pancreatic, Prostate, Sarcoma, Stomach, Testicular, Other”,”treatment_type_terms_string”:”Immunotherapy, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Pancreatic Dream Team: Cutting Off the Fuel Supply: A New Approach in the Treatment of Pancreatic Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/cutting-fuel-supply-to-pancreatic-cancer-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Pancreatic”,”treatment_type_terms_string”:”Chemotherapy, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Epigenetics Dream Team: Bringing Epigenetic Therapy to the Forefront of Cancer Management”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/epigenetics-therapy-2009-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Breast, Colorectal, Leukemia (all types), Lung”,”treatment_type_terms_string”:”Chemotherapy, Epigenetic Therapy, Screening/ Early Detection”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C PI3K Dream Team: Targeting the PI3K Pathway in Women’s Cancers”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/womens-cancers-pi3k-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Breast, Endometiral/Uterin, Ovarian”,”treatment_type_terms_string”:”Chemotherapy, Screening/ Early Detection, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Innovative Research Grant: Therapeutically Targeting the Epigenome in Aggressive Pediatric Cancers”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Pediatric – Solid Tumor”,”treatment_type_terms_string”:”Epigenetic Therapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Cancer Cell Specific, Self-Delivering Pro-Drugs”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Prostate”,”treatment_type_terms_string”:”Chemotherapy, Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Identifying Solid Tumor Kinase Fusions via Exon Capture and 454 Sequencing”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Head and Neck, Leukemia (all types), Lung, Lymphoma, Melanoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Breast Cancer Dream Team: An Integrated Approach to Targeting Breast Cancer Molecular Subtypes and Their Resistance Phenotypes”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/dream-teams/breast-cancer-resistant-phenotypes-dream-team/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Screening/ Early Detection, Other”,”grant_type_terms_string”:”Dream Team”},{“title”:”SU2C Innovative Research Grant: An Emerging Tumor Suppressor Pathway to Human Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Liver, Other”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Modeling Ewing Tumor Initiation in Human Neural Crest Stem Cells”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Pediatric – Solid Tumor, Sarcoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Targeting Inhibition of BCL6 for Leukemia Stem Cell Eradication”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Leukemia (all types), Pediatric – Blood Related”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Endogenous Small Molecules That Regulate Signaling Pathways in Cancer Cells”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Genetic Approaches for Next Generation of Breast Cancer Tailored Programs”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Breast”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Modulating Transcription Factor Abnormalities in Pediatric Cancer”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Pediatric – Solid Tumor, Sarcoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Noninvasive Molecular Profiling of Cancer via Tumor-Derived Microparticles”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Ovarian”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: A Transformative Technology to Capture and Drug New Cancer Targets”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Functional Oncogene Identification”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Leukemia (all types), Lymphoma”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”},{“title”:”SU2C Innovative Research Grant: Probing EBV-LMP-1’s Transmembrane Activation Domain With Synthetic Peptide”,”type”:”research_project”,”url”:”https://standuptocancer.org/research/research-portfolio/irg/2009-irg-recipients/”,”grant_term”:”2009″,”cancer_type_terms_string”:”Non – site Specific”,”treatment_type_terms_string”:”Other”,”grant_type_terms_string”:”Innovative Research Grant”}],”total_count”:146,”total_pages”:0,”type”:”research_project”}

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.